A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Blanchard, P.
Foulon, S.
Artignan, X.
Carles, J.
Ronchin, P.
Gizzi, M.
Villa Freixa, S.
Valdagni, R.
Sargos, P.
Marques Da Costa, L. A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
